Encepur Tick-Borne Encephalitis Vaccine Clinical Trials, Dosage, Safety
Encepur® is a vaccine containing an inactivated and purified Tick-Borne Encephalitis (TBE) virus/strain, prevalent in Central, Eastern, and Northern Europe. In areas where the disease is highly endemic, the World Health Organization recommends that vaccination be offered to all age groups, including children.
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines.
Encepur Vaccine Indication
Encepur is indicated for actively immunizing high-risk populations against TBE.
Encepur Vaccine Dosage
Encepur is administered as an intramuscular injection. It has unique dosing flexibility supported by proven efficacy and long-term persistence data.
Encepur Vaccine Availability
The vaccine is marketed in European countries only, with Germany being the largest market, representing approximately 80% of the product's total revenue.
Encepur Vaccine News
October 21, 2019: Bavarian Nordic announced that it has entered an agreement with GlaxoSmithKline to acquire the manufacturing and global rights to Rabipur®/RabAvert® and Encepur®, two commercial vaccines with combined annual sales of approximately EUR 175 million, holding strong positions in growing markets. Rabipur/RabAvert provides pre- and post-exposure protection against rabies, while Encepur protects against European (Western) tick-borne encephalitis (TBE) virus.
Encepur Vaccine Clinical Trials
Clinical Trial NCT03294135: This Study aims to investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine
- The purpose of this study is to continue the evaluation of antibody persistence through 11 to 15 years after the first booster with the Tick-Borne Encephalitis (TBE) vaccine.
- This study will further investigate the booster response in subjects who will receive their second booster dose* in this study.
* Any booster given in this study will be the second the subject has received (about the follow-up of the previous study).